Dashboard
1
Poor long term growth as Net Sales has grown by an annual rate of -21.49% and Operating profit at -53.59% over the last 5 years
2
The company has declared negative results in Mar'2025 after 4 consecutive positive quarters
3
With ROE of 2.56%, it has a very attractive valuation with a 0.33 Price to Book Value
4
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Chemicals & Petrochemicals
CNY 1,358 Million (Small Cap)
53.00
NA
0.00%
-0.18
2.11%
0.31
Revenue and Profits:
Net Sales:
158 Million
(Quarterly Results - Sep 2025)
Net Profit:
10 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.55%
0%
7.55%
6 Months
-2.87%
0%
-2.87%
1 Year
15.66%
0%
15.66%
2 Years
19.04%
0%
19.04%
3 Years
-20.32%
0%
-20.32%
4 Years
-60.25%
0%
-60.25%
5 Years
0%
0%
0.0%
Shandong Sanyuan Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-10.28%
EBIT Growth (5y)
-41.22%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.49
Sales to Capital Employed (avg)
0.13
Tax Ratio
19.15%
Dividend Payout Ratio
269.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.47%
ROE (avg)
4.43%
Valuation key factors
Factor
Value
P/E Ratio
53
Industry P/E
Price to Book Value
1.35
EV to EBIT
128.64
EV to EBITDA
45.85
EV to Capital Employed
1.43
EV to Sales
7.82
PEG Ratio
1.24
Dividend Yield
NA
ROCE (Latest)
1.11%
ROE (Latest)
2.56%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
158.10
137.30
15.15%
Operating Profit (PBDIT) excl Other Income
-4.70
20.10
-123.38%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
9.90
29.10
-65.98%
Operating Profit Margin (Excl OI)
-30.00%
19.20%
-4.92%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is 15.15% vs 18.46% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -65.98% vs 246.43% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
712.90
499.50
42.72%
Operating Profit (PBDIT) excl Other Income
73.70
0.20
36,750.00%
Interest
0.30
0.20
50.00%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
105.00
58.90
78.27%
Operating Profit Margin (Excl OI)
10.50%
-119.00%
12.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 42.72% vs -25.99% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 78.27% vs -64.02% in Dec 2023
About Shandong Sanyuan Biotechnology Co., Ltd. 
Shandong Sanyuan Biotechnology Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






